Opko Health, Inc.
OPK
$1.31
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 587.90M | 581.12M | 606.88M | 642.07M | 664.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 587.90M | 581.12M | 606.88M | 642.07M | 664.03M |
| Cost of Revenue | 442.45M | 466.30M | 496.83M | 509.04M | 539.46M |
| Gross Profit | 145.44M | 114.83M | 110.05M | 133.03M | 124.57M |
| SG&A Expenses | 210.55M | 217.22M | 227.70M | 238.32M | 282.72M |
| Depreciation & Amortization | 76.52M | 77.00M | 77.89M | 79.18M | 80.08M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 760.49M | 788.66M | 830.56M | 854.67M | 930.39M |
| Operating Income | -172.60M | -207.54M | -223.69M | -212.61M | -266.37M |
| Income Before Tax | -79.85M | -228.97M | -241.39M | -159.50M | -152.51M |
| Income Tax Expenses | -6.96M | -16.05M | -15.71M | 20.89M | 24.62M |
| Earnings from Continuing Operations | -72.89 | -212.92 | -225.68 | -180.40 | -177.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.89M | -212.92M | -225.68M | -180.40M | -177.14M |
| EBIT | -172.60M | -207.54M | -223.69M | -212.61M | -266.37M |
| EBITDA | -82.87M | -117.19M | -132.06M | -119.32M | -171.65M |
| EPS Basic | -0.10 | -0.27 | -0.30 | -0.24 | -0.23 |
| Normalized Basic EPS | -0.16 | -0.27 | -0.29 | -0.11 | -0.17 |
| EPS Diluted | -0.10 | -0.27 | -0.30 | -0.24 | -0.24 |
| Normalized Diluted EPS | -0.16 | -0.27 | -0.29 | -0.15 | -0.17 |
| Average Basic Shares Outstanding | 3.06B | 3.09B | 3.00B | 2.91B | 2.83B |
| Average Diluted Shares Outstanding | 3.06B | 3.09B | 3.01B | 3.19B | 3.41B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |